← Back to Search

Orthopedic Implant

Anser Clavicle Pin for Collarbone Fracture

N/A
Waitlist Available
Led By Jonathan Braman, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Displaced midshaft clavicle fracture Type 2B according to the Robinson Classification
Skeletally mature
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year post-operation
Awards & highlights

Study Summary

This trial will study the Anser Clavicle Pin, which is approved by the FDA, in 50 patients to see how well it works, how satisfied patients are with it, and what its functional results are.

Eligible Conditions
  • Collarbone Fracture

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year post-operation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year post-operation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ASES Score- 1 year
ASES Score- 2 week
ASES Score- 3 month
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Anser Clavicle PinExperimental Treatment1 Intervention
Patients treated with Anser Clavicle Pin in the setting of a displaced midshaft clavicle fracture

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,367 Previous Clinical Trials
1,587,459 Total Patients Enrolled
Jonathan Braman, MDPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still slots available for this clinical experiment?

"According to the clinicaltrials.gov website, this clinical trial has concluded its recruitment process and is no longer seeking participants. Initially posted on September 1st 2023 and last updated October 5th 2022, there are now 349 other medical studies actively accepting patients into their trials."

Answered by AI
~33 spots leftby Jan 2030